About Rachel Rosovsky, MD, MPH

Dr. Rachel Rosovsky is a hematologist and clinical investigator at the Massachusetts General Hospital (MGH) and Associate Professor at Harvard Medical School.  She is also the Director of Thrombosis Research in Division of Hematology at MGH and Co-Chair of MGH’s Thrombosis Committee.  

Dr. Rosovsky specializes in disorders of clotting and bleeding as well as anemia and thrombocytopenia.  Her clinical practice is devoted to the risks, diagnosis and treatment of clotting conditions such as pulmonary embolism (PE), deep vein thrombosis (DVT), cancer associated thrombosis, and antiphospholipid syndrome. As a clinical investigator, Dr. Rosovsky serves as the principle investigator for several clinical trials and is able to offer new treatment options to patients with these conditions.  Dr. Rosovsky is also the creator/director of Pulmonary Embolism Response Team multidisciplinary follow up clinic as well as runs the outpatient low risk PE and DVT clinic and patients with clotting problems are encouraged to schedule an appointment with Dr. Rosovsky

Dr. Rosovsky earned her undergraduate degree from University of Pennsylvania, medical degree from Harvard Medical School and Master's in Public Health from Harvard School of Public Health. She completed residency at Brigham and Women's Hospital and fellowship in hematology and medical oncology at the Dana-Farber Cancer Institute-Massachusetts General Hospital combined program.  

Dr. Rosovsky is one of the founders and President-Elect of Pulmonary Embolism Response Team Consortium, an organization focused on improving the care of patients with PE worldwide.  She is on Medical/Scientific Advisory Board for National Blood Clot Alliance (NBCA), a patient advocacy organization and on Executive Committee for Venous thromboEmbolism Network US (VENUS), a network of USA institutions that collaborate on thrombosis care and research.  Since COVID-19 pandemic, she has been actively involved in investigating how COVID-19 and coagulopathy are affecting patients throughout the globe.  Through research and clinical work, Dr. Rosovsky has sought to improve care of patients with blood clots and advance the understanding and treatment of this medical condition for the past 20 years.

Departments, Centers, & Programs:

Clinical Interests:



Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-726-5130
Phone: 877-726-5130

Medical Education

  • MPH, Harvard School of Public Health
  • Residency, Brigham and Women's Hospital
  • Fellowship, Brigham and Women's Hospital
  • Fellowship, Dana Farber Cancer Institute

American Board Certifications

  • Hematology, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Rosovsky conducts research on disorders of thrombosis and hemostasis. She runs clinical trials focused on the risks, diagnosis, and treatment outcomes in patients with clotting and bleeding conditions. She has published over 90 scholarly manuscripts in these areas and has presented numerous research and clinical presentations at national and international scientific conferences. Her research has appeared in New England Journal of Medicine, Chest, Blood, Annals of Internal Medicine, Journal of Thrombosis and Hemostasis, and The Oncologist.


  • https://pubmed.ncbi.nlm.nih.gov/?term=Rosovsky%2C+r&sort=date&size=200

    Rosovsky RP, Grodzin C, Channick R, Davis GA, Giri JS, Horowitz J, Kabrhel C, Lookstein R, Merli G, Morris TA, Rivera-Lebron B, Tapson V, Todoran TM, Weinberg AS, Rosenfield K; PERT Consortium. Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium. Chest. 2020 Dec;158(6):2590-2601. doi: 10.1016/j.chest.2020.08.2064. Epub 2020 Aug 27. PMID: 32861692; PMCID: PMC7450258.

    Rosovsky RP, Sanfilippo KM, Wang TF, Rajan SK, Shah S, Martin KA, Ni Ainle F, Huisman M, Hunt BJ, Kahn SR, Kevane B, Lee AY, McLintock C, Baumann Kreuziger L. Anticoagulation Practice Patterns in COVID-19: A Global Survey. Res Pract Thromb Haemost. 2020 Jul 9;4(6):969?83. doi: 10.1002/rth2.12414. Epub ahead of print. PMID: 32838111; PMCID: PMC7361754.

    Li A, Kuderer NM, Hsu CY, Shyr Y, Warner JL, Shah DP, Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP; CCC19 consortium. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 Oct;19(10):2522-2532. doi: 10.1111/jth.15463. Epub 2021 Aug 13. PMID: 34260813; PMCID: PMC8420489.

    Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520. PMID: 32492712; PMCID: PMC7378457.

    Giustozzi M, Agnelli G, Del Toro-Cervera J, Klok FA, Rosovsky RP, Martin AC, Herold J, Tzoran I, Szmit S, Bertoletti L, Becattini C, Huisman MV. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis. Thromb Haemost. 2020 Jul;120(7):1128-1136. doi: 10.1055/s-0040-1712098. Epub 2020 May 4. PMID: 32365386.

    Cohen AJ, Boggio L, Billett HH, DeSancho MT, Gaddh M, Kouides P, Lim M, Nyak L, Rajan S, Rosovsky R, Streiff M, Wang TF, Baumann Kreuziger L. North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. J Women's Health (Larchmt). 2021 Jun;30(6):829-836. doi: 10.1089/jwh.2020.8385. Epub 2020 Nov 24. PMID: 33232187.

    Rosovsky RP, Barra ME, Roberts RJ, Parmar A, Andonian J, Suh L, Algeri S, Biddinger PD. When Pigs Fly: A Multidisciplinary Approach to Navigating a Critical Heparin Shortage. Oncologist. 2020 Apr;25(4):334-347. doi: 10.1634/theoncologist.2019-0910. Epub 2020 Mar 10. PMID: 32154634; PMCID: PMC7160421.

    Baugh CW, Levine M, Cornutt D, Wilson JW, Kwun R, Mahan CE, Pollack CV Jr, Marcolini EG, Milling TJ Jr, Peacock WF, Rosovsky RP, Wu F, Sarode R, Spyropoulos AC, Villines TC, Woods TD, McManus J, Williams J. Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel. Ann Emerg Med. 2020 Oct;76(4):470-485. doi: 10.1016/j.annemergmed.2019.09.001. Epub 2019 Nov 13. PMID: 31732375; PMCID: PMC7393606.

    Gaddh M, Rosovsky RP. Venous Thromboembolism: Genetics and Thrombophilias. Semin Respir Crit Care Med. 2021 Apr;42(2):271-283. doi: 10.1055/s-0041-1723937. Epub 2021 Mar 10. PMID: 33694139.

    Boon GJAM, Barco S, Bertoletti L, Ghanima W, Huisman MV, Kahn SR, Noble S, Prandoni P, Rosovsky RP, Sista AK, Siegerink B, Klok FA. Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale. Thromb Res. 2020 Jun;190:45-51. doi: 10.1016/j.thromres.2020.03.020. Epub 2020 Mar 30. PMID: 32298840.

    Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan;47(1):31-40. doi: 10.1007/s11239-018-1737-8. Erratum in: J Thromb Thrombolysis. 2018 Nov 30;: PMID: 30242551.

Reviews: Comments and Ratings